Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pizer, E. S.
Right arrow Articles by Kuhajda, F. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pizer, E. S.
Right arrow Articles by Kuhajda, F. P.
[Cancer Research 60, 213-218, January 15, 2000]
© 2000 American Association for Cancer Research


Advances in Brief

Malonyl-Coenzyme-A Is a Potential Mediator of Cytotoxicity Induced by Fatty-Acid Synthase Inhibition in Human Breast Cancer Cells and Xenografts1

Ellen S. Pizer, Jagan Thupari, Wan Fang Han, Michael L. Pinn, Francis J. Chrest, Gojeb L. Frehywot, Craig A. Townsend and Francis P. Kuhajda2

Department of Pathology, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21224 [E. S. P., J. T., W. F. H., M. L. P., F. P. K.]; Research Resources Branch/Flow Cytometry Unit, Gerontology Research Center, National Institute on Aging, Baltimore, Maryland 21224 [F. J. C.]; and Department of Chemistry, The Johns Hopkins University, Baltimore, Maryland 21218 [G. L. F., C. A. T.]

A biologically aggressive subset of human breast cancers and other malignancies is characterized by elevated fatty-acid synthase (FAS) enzyme expression, elevated fatty acid (FA) synthesis, and selective sensitivity to pharmacological inhibition of FAS activity by cerulenin or the novel compound C75. In this study, inhibition of FA synthesis at the physiologically regulated step of carboxylation of acetyl-CoA to malonyl-CoA by 5-(tetradecyloxy)-2-furoic acid (TOFA) was not cytotoxic to breast cancer cells in clonogenic assays. FAS inhibitors induced a rapid increase in intracellular malonyl-CoA to several fold above control levels, whereas TOFA reduced intracellular malonyl-CoA by 60%. Simultaneous exposure of breast cancer cells to TOFA and an FAS inhibitor resulted in significantly reduced cytotoxicity and apoptosis. Subcutaneous xenografts of MCF7 breast cancer cells in nude mice treated with C75 showed FA synthesis inhibition, apoptosis, and inhibition of tumor growth to less than 1/8 of control volumes, without comparable toxicity in normal tissues. The data suggest that differences in intermediary metabolism render tumor cells susceptible to toxic fluxes in malonyl-CoA, both in vitro and in vivo.




This article has been cited by other articles:


Home page
Mol. Interv.Home page
S. R. Bloom, F. P. Kuhajda, I. Laher, X. Pi-Sunyer, G. V. Ronnett, T. M.M. Tan, and D. S. Weigle
The Obesity Epidemic: Pharmacological Challenges
Mol. Interv., April 1, 2008; 8(2): 82 - 98.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
S. Aja, L. E. Landree, A. M. Kleman, S. M. Medghalchi, A. Vadlamudi, J. M. McFadden, A. Aplasca, J. Hyun, E. Plummer, K. Daniels, et al.
Pharmacological stimulation of brain carnitine palmitoyl-transferase-1 decreases food intake and body weight
Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2008; 294(2): R352 - R361.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
H. Orita, J. Coulter, C. Lemmon, E. Tully, A. Vadlamudi, S. M. Medghalchi, F. P. Kuhajda, and E. Gabrielson
Selective Inhibition of Fatty Acid Synthase for Lung Cancer Treatment
Clin. Cancer Res., December 1, 2007; 13(23): 7139 - 7145.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Beckers, S. Organe, L. Timmermans, K. Scheys, A. Peeters, K. Brusselmans, G. Verhoeven, and J. V. Swinnen
Chemical Inhibition of Acetyl-CoA Carboxylase Induces Growth Arrest and Cytotoxicity Selectively in Cancer Cells
Cancer Res., September 1, 2007; 67(17): 8180 - 8187.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
W. Zhou, W. F. Han, L. E. Landree, J. N. Thupari, M. L. Pinn, T. Bililign, E. K. Kim, A. Vadlamudi, S. M. Medghalchi, R. El Meskini, et al.
Fatty Acid Synthase Inhibition Activates AMP-Activated Protein Kinase in SKOV3 Human Ovarian Cancer Cells
Cancer Res., April 1, 2007; 67(7): 2964 - 2971.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. Priolo, D. Tang, M. Brahamandan, B. Benassi, E. Sicinska, S. Ogino, A. Farsetti, A. Porrello, S. Finn, J. Zimmermann, et al.
The Isopeptidase USP2a Protects Human Prostate Cancer from Apoptosis.
Cancer Res., September 1, 2006; 66(17): 8625 - 8632.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
W. B. Kinlaw, J. L. Quinn, W. A. Wells, C. Roser-Jones, and J. T. Moncur
Spot 14: A Marker of Aggressive Breast Cancer and a Potential Therapeutic Target
Endocrinology, September 1, 2006; 147(9): 4048 - 4055.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
R. Lupu and J. A. Menendez
Targeting Fatty Acid Synthase in Breast and Endometrial Cancer: An Alternative to Selective Estrogen Receptor Modulators?
Endocrinology, September 1, 2006; 147(9): 4056 - 4066.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y.-M. Zhang, S. W. White, and C. O. Rock
Inhibiting Bacterial Fatty Acid Synthesis
J. Biol. Chem., June 30, 2006; 281(26): 17541 - 17544.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
F. P. Kuhajda
Fatty Acid synthase and cancer: new application of an old pathway.
Cancer Res., June 15, 2006; 66(12): 5977 - 5980.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Bandyopadhyay, R. Zhan, Y. Wang, S. K. Pai, S. Hirota, S. Hosobe, Y. Takano, K. Saito, E. Furuta, M. Iiizumi, et al.
Mechanism of Apoptosis Induced by the Inhibition of Fatty Acid Synthase in Breast Cancer Cells
Cancer Res., June 1, 2006; 66(11): 5934 - 5940.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
V. Chajes, M. Cambot, K. Moreau, G. M. Lenoir, and V. Joulin
Acetyl-CoA Carboxylase {alpha} Is Essential to Breast Cancer Cell Survival.
Cancer Res., May 15, 2006; 66(10): 5287 - 5294.
[Abstract] [Full Text] [PDF]


Home page
Annals of Clinical & Laboratory ScienceHome page
X. Zhang and F. L. Kiechle
Fatty Acid Synthase and its mRNA Concentrations Are Decreased at Different Times Following Hoechst 33342-induced Apoptosis in BC3H-1 Myocytes.
Ann. Clin. Lab. Sci., March 1, 2006; 36(2): 185 - 193.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
Y. Chang, J. Wang, X. Lu, D. P. Thewke, and R. J. Mason
KGF induces lipogenic genes through a PI3K and JNK/SREBP-1 pathway in H292 cells
J. Lipid Res., December 1, 2005; 46(12): 2624 - 2635.
[Abstract] [Full Text] [PDF]


Home page
J BiochemHome page
B.-H. Li, X.-F. Ma, Y. Wang, and W.-X. Tian
Structure-Activity Relationship of Polyphenols That Inhibit Fatty Acid Synthase
J. Biochem., December 1, 2005; 138(6): 679 - 685.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. Brusselmans, E. De Schrijver, G. Verhoeven, and J. V. Swinnen
RNA Interference-Mediated Silencing of the Acetyl-CoA-Carboxylase-{alpha} Gene Induces Growth Inhibition and Apoptosis of Prostate Cancer Cells
Cancer Res., August 1, 2005; 65(15): 6719 - 6725.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
J. A. Menendez, L. Vellon, and R. Lupu
Antitumoral actions of the anti-obesity drug orlistat (XenicalTM) in breast cancer cells: blockade of cell cycle progression, promotion of apoptotic cell death and PEA3-mediated transcriptional repression of Her2/neu (erbB-2) oncogene
Ann. Onc., August 1, 2005; 16(8): 1253 - 1267.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Brusselmans, R. Vrolix, G. Verhoeven, and J. V. Swinnen
Induction of Cancer Cell Apoptosis by Flavonoids Is Associated with Their Ability to Inhibit Fatty Acid Synthase Activity
J. Biol. Chem., February 18, 2005; 280(7): 5636 - 5645.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. Lu and M. C. Archer
Fatty acid synthase is a potential molecular target for the chemoprevention of breast cancer
Carcinogenesis, January 1, 2005; 26(1): 153 - 157.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
O. M. Sinilnikova, S. M. Ginolhac, C. Magnard, M. Leone, O. Anczukow, D. Hughes, K. Moreau, D. Thompson, C. Coutanson, J. Hall, et al.
Acetyl-CoA carboxylase {alpha} gene and breast cancer susceptibility
Carcinogenesis, December 1, 2004; 25(12): 2417 - 2424.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. L. Ettinger, R. Sobel, T. G. Whitmore, M. Akbari, D. R. Bradley, M. E. Gleave, and C. C. Nelson
Dysregulation of Sterol Response Element-Binding Proteins and Downstream Effectors in Prostate Cancer during Progression to Androgen Independence
Cancer Res., March 15, 2004; 64(6): 2212 - 2221.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
A. Vecchini, V. Ceccarelli, F. Susta, P. Caligiana, P. Orvietani, L. Binaglia, G. Nocentini, C. Riccardi, G. Calviello, P. Palozza, et al.
Dietary {alpha}-linolenic acid reduces COX-2 expression and induces apoptosis of hepatoma cells
J. Lipid Res., February 1, 2004; 45(2): 308 - 316.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
W. Zhou, P. J. Simpson, J. M. McFadden, C. A. Townsend, S. M. Medghalchi, A. Vadlamudi, M. L. Pinn, G. V. Ronnett, and F. P. Kuhajda
Fatty Acid Synthase Inhibition Triggers Apoptosis during S Phase in Human Cancer Cells
Cancer Res., November 1, 2003; 63(21): 7330 - 7337.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
E. De Schrijver, K. Brusselmans, W. Heyns, G. Verhoeven, and J. V. Swinnen
RNA Interference-mediated Silencing of the Fatty Acid Synthase Gene Attenuates Growth and Induces Morphological Changes and Apoptosis of LNCaP Prostate Cancer Cells
Cancer Res., July 1, 2003; 63(13): 3799 - 3804.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
F. D. Camassei, R. Cozza, A. Acquaviva, A. Jenkner, L. Rava, R. Gareri, A. Donfrancesco, C. Bosman, P. Vadala, T. Hadjistilianou, et al.
Expression of the Lipogenic Enzyme Fatty Acid Synthase (FAS) in Retinoblastoma and Its Correlation with Tumor Aggressiveness
Invest. Ophthalmol. Vis. Sci., June 1, 2003; 44(6): 2399 - 2403.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. S. Chirala, H. Chang, M. Matzuk, L. Abu-Elheiga, J. Mao, K. Mahon, M. Finegold, and S. J. Wakil
Fatty acid synthesis is essential in embryonic development: Fatty acid synthase null mutants and most of the heterozygotes die in utero
PNAS, May 27, 2003; 100(11): 6358 - 6363.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
M. Gilbert, C. Magnan, S. Turban, J. Andre, and M. Guerre-Millo
Leptin Receptor-Deficient Obese Zucker Rats Reduce Their Food Intake in Response to a Systemic Supply of Calories From Glucose
Diabetes, February 1, 2003; 52(2): 277 - 282.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. Kumar-Sinha, K. W. Ignatoski, M. E. Lippman, S. P. Ethier, and A. M. Chinnaiyan
Transcriptome Analysis of HER2 Reveals a Molecular Connection to Fatty Acid Synthesis
Cancer Res., January 1, 2003; 63(1): 132 - 139.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
M. Prentki, E. Joly, W. El-Assaad, and R. Roduit
Malonyl-CoA Signaling, Lipid Partitioning, and Glucolipotoxicity: Role in {beta}-Cell Adaptation and Failure in the Etiology of Diabetes
Diabetes, December 1, 2002; 51(90003): S405 - 413.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. N. Thupari, L. E. Landree, G. V. Ronnett, and F. P. Kuhajda
C75 increases peripheral energy utilization and fatty acid oxidation in diet-induced obesity
PNAS, July 9, 2002; 99(14): 9498 - 9502.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
S. G. Straub, H. Yajima, M. Komatsu, T. Aizawa, and G. W.G. Sharp
The Effects of Cerulenin, an Inhibitor of Protein Acylation, on the Two Phases of Glucose-Stimulated Insulin Secretion
Diabetes, February 1, 2002; 51(90001): S91 - 95.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J.-N. Li, M. Gorospe, F. J. Chrest, T. S. Kumaravel, M. K. Evans, W. F. Han, and E. S. Pizer
Pharmacological Inhibition of Fatty Acid Synthase Activity Produces Both Cytostatic and Cytotoxic Effects Modulated by p53
Cancer Res., February 1, 2001; 61(4): 1493 - 1499.
[Abstract] [Full Text]


Home page
Clin. Cancer Res.Home page
E. W. Gabrielson, M. L. Pinn, J. R. Testa, and F. P. Kuhajda
Increased Fatty Acid Synthase is a Therapeutic Target in Mesothelioma
Clin. Cancer Res., January 1, 2001; 7(1): 153 - 157.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
S. W. Ki, K. Ishigami, T. Kitahara, K. Kasahara, M. Yoshida, and S. Horinouchi
Radicicol Binds and Inhibits Mammalian ATP Citrate Lyase
J. Biol. Chem., December 8, 2000; 275(50): 39231 - 39236.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
F. P. Kuhajda, E. S. Pizer, J. N. Li, N. S. Mani, G. L. Frehywot, and C. A. Townsend
Synthesis and antitumor activity of an inhibitor of fatty acid synthase
PNAS, March 28, 2000; 97(7): 3450 - 3454.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2000 by the American Association for Cancer Research.